41S RIO GRANDE STREET, SALT LAKE CITY, UT
Reports Second Quarter Financial Results; Options First Neuroscience Target into Early Discovery Program
Stockholders Elect Najat Khan and Franziska Michor as Class II Directors
Reports First Quarter Financial Results and Provides Business Update
Annual Report to Security Holders
Announces Board Transition
Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Investor Presentation
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Definitive Merger Proxy Statement
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)